In conclusion, we show that signaling downstream of the EGFR differs between cell lines, but β4 or its tyrosine phosphorylation does not affect the signaling of the EGFR, neither in cancer cells nor in non-cancerous epithelial cells. The gene discussed is EGFR; the disease is cancer.